GRP
AVEO

Global Retirement Partners’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Global Retirement Partners’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-36
Closed -$1K – 1562
2017
Q4 		$1K Hold
36
– – ﹤0.01% 1413
2017
Q3 		$1K Hold
36
– – ﹤0.01% 1198
2017
Q2 		$1K Hold
36
– – ﹤0.01% 1122
2017
Q1 		$0 Hold
36
– – ﹤0.01% 1165
2016
Q4 		$0 Buy
+36
New +$240 ﹤0.01% 1053

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Global Retirement Partners's AVEO Position: Q1 2018 in Review

Global Retirement Partners sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2018, closing a stake of 36 shares — an estimated $1K sold.

Global Retirement Partners first reported a position in AVEO in Q4 2016 and held it in 5 quarters. The position peaked at $1K in Q4 2017. 90 funds tracked by Wall St. Rank hold AVEO as of Q1 2018.

  • Global Retirement Partners reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Global Retirement Partners sold 36 AVEO Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1K.
  • Global Retirement Partners first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2016 and held it in 5 quarters.
  • Global Retirement Partners's AVEO Pharmaceuticals, Inc. position peaked at $1K in Q4 2017.
  • 90 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2018.

Based on Global Retirement Partners's 13F filing for Q1 2018, filed 10 Aug 2018.